A smartphone app to help manage depression symptoms
Treating Depression on a Day-to-day Basis: Development of a Novel Clinical Tool for Physicians Based on a Smartphone Application, the SMART Project (Smartphones and Mood Disorders, an Application for Research and Treatment)
NA · Centre Hospitalier Charles Perrens, Bordeaux · NCT03678194
This study is testing a smartphone app that helps people with depression track their symptoms and treatment to see if it can improve their care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Charles Perrens, Bordeaux (other gov) |
| Locations | 1 site (Bordeaux) |
| Trial ID | NCT03678194 on ClinicalTrials.gov |
What this trial studies
This study tests and validates a smartphone application designed to monitor and understand daily symptoms of depression, medication adherence, and treatment effectiveness. By utilizing Ecological Momentary Assessment (EMA), the app collects real-time data from patients in their daily lives, aiming to identify factors that influence mood fluctuations and adherence to treatment. The goal is to enhance patient care by providing insights that can lead to tailored interventions based on individual patient needs.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 who have recently started antidepressant treatment and meet the criteria for depression.
Not a fit: Patients with severe psychiatric disorders such as schizophrenia or bipolar disorder, or those unable to use the smartphone app due to cognitive or sensory impairments, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management of depression by enabling personalized treatment strategies.
How similar studies have performed: Previous studies using similar EMA approaches in psychiatry have shown promising results in understanding mood disorders and improving treatment adherence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years; * Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview; * Patients started their antidepressant treatment less than 5 days before inclusion; * Patient treated in an outpatient setting; * Patient informed of the diagnosis of his disease; * Informed patient with written consent. Exclusion Criteria: * A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward; * A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features; * Cognitive deficit and not thus being able to comprehend the informed consent and study procedure; * Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….); * Non-comprehension of the French language
Where this trial is running
Bordeaux
- Centre Hospitalier Charles PERRENS — Bordeaux, France (RECRUITING)
Study contacts
- Study coordinator: David MISDRAHI, M.D
- Email: dmisdrahi@ch-perrens.fr
- Phone: +33(0)556563449
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Depression, Psychiatric Disorder, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Smartphone, Relapse prevention, Mobile support system